surmount-1 tirzepatide weight loss percent nejm 2022 Trial — 22.5% Tirzepatide for maintenance of bodyweight
Description
You may need more time on a higher dose
00656-2/asset/ccb5d465-a316-405d-847e-f889e2a34a2c/main.assets/gr3_lrg.jpg)
While effective, potential side effects include nausea and constipation
Additionally, this medication is not recommended for pregnant or breastfeeding women, as its safety in these populations has not been established
They may also recommend prescription-strength medications like lubiprostone (Amitiza) or linaclotide (Linzess) if over-the-counter options prove insufficient
It is important to maintain open communication with your healthcare team about all side effects or concerns you experience while taking tirzepatide
After 4 weeks at 2.5 mg, stop injecting
